Comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience

Comment on: Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience

Bibliographic Details
Main Authors:	Vidhi Kathiriya, Minal Kanhere, Yash Gala, Suresh Ramchandani
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Indian Journal of Ophthalmology
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2018;volume=66;issue=2;spage=348;epage=349;aulast=Kathiriya

Similar Items

Aflibercept for recurrent or recalcitrant polypoidal choroidal vasculopathy in Indian eyes: Early experience
by: Aditya Bansal, et al.
Published: (2017-01-01)

Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2020-07-01)

Comment on: To assess survival outcomes of combined femtosecond laser-assisted cataract surgery with 25-gauge vitrectomy surgery at a tertiary eye care center
by: Neeraj Ashok Israni, et al.
Published: (2017-01-01)

AFLIBERCEPT IN TREATMENT OF RESISTANT POLYPOID CHOROIDAL VASCULOPATHY: SHORT-TERM RESULTS
by: E. K. Pedanova, et al.
Published: (2017-12-01)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
by: Miura M, et al.
Published: (2013-08-01)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
by: Arakawa A, et al.
Published: (2017-04-01)

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy
by: Miyakubo T, et al.
Published: (2023-02-01)

Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Choroidal structure as a biomarker for visual acuity in intravitreal aflibercept therapy for polypoidal choroidal vasculopathy.
by: Shotaro Asano, et al.
Published: (2018-01-01)

Polypoidal Choroidal Vasculopathy
by: Mirza Metita, et al.
Published: (2018-08-01)

Effect of polyp regression and reduction on treatment efficacy in polypoidal choroidal vasculopathy treated with aflibercept
by: Kaori Sayanagi, et al.
Published: (2024-01-01)

Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy
by: Young-Joon Jeon, et al.
Published: (2021-12-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy
by: Sumit Randhir Singh, et al.
Published: (2019-01-01)

Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept
by: Yin Xue, et al.
Published: (2022-02-01)

Commentary: Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
by: Giridhar Anantharaman
Published: (2019-01-01)

Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India
by: Jay U Sheth, et al.
Published: (2022-01-01)

Idiopathic polypoidal choroidal vasculopathy
by: Cekić Sonja, et al.
Published: (2012-01-01)

One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2019-05-01)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
by: Kumar Anshuman, et al.
Published: (2019-01-01)

One-Year Results of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy
by: Tomoko Tamachi, et al.
Published: (2020-10-01)

Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results.
by: Mio Matsubara, et al.
Published: (2020-01-01)

Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2021-01-01)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Kikushima Wataru, et al.
Published: (2020-01-01)

Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy.
by: Arisa Ito, et al.
Published: (2020-01-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Evolution of Polypoidal Lesions after Treatment of Polypoidal Choroidal Vasculopathy
by: Colin S. Tan, MMed (Ophth), FRCOphth, et al.
Published: (2022-03-01)

Effect of Epiretinal Membrane Peeling on Intravitreal Aflibercept Therapy Response for Polypoidal Choroidal Vasculopathy: A Case Report
by: Aslı Kırmacı, et al.
Published: (2018-04-01)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
by: Ki Won Jin, et al.
Published: (2021-07-01)

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab
by: James G. Wong, et al.
Published: (2017-04-01)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Wataru Kikushima, et al.
Published: (2020-01-01)

Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
by: DebdulalChakraborty, et al.
Published: (2022-01-01)

Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy
by: Kenji Yamashiro, et al.
Published: (2022-08-01)

New Concepts for the Diagnosis of Polypoidal Choroidal Vasculopathy
by: Jinzhi Zhao, et al.
Published: (2023-05-01)

Polypoidal Choroidal Vasculopathy: An Update on Therapeutic Approaches
by: Raymond L.M. Wong, et al.
Published: (2013-01-01)

Treatment Outcomes in Patients with Polypoidal Choroidal Vasculopathy
by: Mümin Hocaoğlu, et al.
Published: (2016-01-01)

Polypoidal Choroidal Vasculopathy: An Update on Diagnosis and Treatment
by: Sen P, et al.
Published: (2023-01-01)

Current management strategy of polypoidal choroidal vasculopathy
by: Christine P S Ho, et al.
Published: (2018-01-01)

Role of Photodynamic Therapy in Polypoidal Choroidal Vasculopathy
by: Hussain Nazimul, et al.
Published: (2005-01-01)

OCT and OCTA observation of polypoidal choroidal vasculopathy
by: Yan-Hong Liao, et al.
Published: (2019-10-01)